data_1opz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1opz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 tpp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.72 163.52 31.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.913 1.285 . . . . 10.0 107.617 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.45 104.82 4.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 166.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -116.14 125.07 51.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -83.33 160.79 21.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.931 -171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -142.04 152.16 43.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.717 0.77 . . . . 10.0 109.823 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.98 133.62 34.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.38 2.272 . . . . 10.0 106.913 168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -113.09 148.39 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.965 -1.865 . . . . 10.0 105.965 159.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.11 124.95 25.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -156.21 167.72 29.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 -168.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.405 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -100.59 151.09 22.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -171.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.76 156.52 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB3' ' CD2' ' A' ' 70' ' ' HIS . 5.7 t -115.32 140.92 48.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.71 59.29 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.243 -0.754 . . . . 10.0 114.115 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.9 125.92 14.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.859 1.329 . . . . 10.0 110.938 172.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -112.99 49.99 0.91 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t 51.35 -136.28 1.33 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.246 -1.359 . . . . 10.0 110.282 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 32.93 57.27 0.45 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.936 1.694 . . . . 10.0 114.021 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.05 20.79 7.2 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.05 1.34 . . . . 10.0 114.29 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -70.41 -60.66 2.14 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.203 -0.936 . . . . 10.0 108.66 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.31 71.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.164 0.507 . . . . 10.0 111.428 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.72 79.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.97 -0.456 . . . . 10.0 110.475 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -55.6 -50.15 70.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.542 0.61 . . . . 10.0 110.707 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.8 mt -47.72 -60.97 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.46 -34.46 70.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.313 -0.555 . . . . 10.0 111.097 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -57.79 -35.12 70.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.016 -1.052 . . . . 10.0 110.751 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.96 -51.09 41.99 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.452 -1.059 . . . . 10.0 110.452 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.84 -30.55 71.56 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.288 -1.125 . . . . 10.0 113.17 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -58.07 -17.9 21.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.368 0.985 . . . . 10.0 111.658 171.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -15.44 58.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.253 1.205 . . . . 10.0 114.253 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 99.2 mmm -77.24 134.82 66.69 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 120.537 1.517 . . . . 10.0 112.448 -170.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 102.48 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.118 2.545 . . . . 10.0 111.006 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.89 -9.55 6.74 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.764 1.649 . . . . 10.0 110.272 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.48 155.94 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 118.218 1.009 . . . . 10.0 109.807 164.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -58.67 1.92 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 167.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.29 157.86 43.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.249 1.203 . . . . 10.0 114.249 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.93 37.88 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.391 1.876 . . . . 10.0 109.087 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -138.25 111.2 7.76 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.18 1.392 . . . . 10.0 108.572 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -84.54 140.35 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.629 0.771 . . . . 10.0 110.754 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -131.44 67.32 1.52 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.259 1.824 . . . . 10.0 111.526 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.37 -18.15 63.75 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.36 -16.42 22.59 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.017 0.371 . . . . 10.0 110.773 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -129.89 20.34 5.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.314 1.045 . . . . 10.0 110.093 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 47.12 37.92 5.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.348 0.976 . . . . 10.0 112.278 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.5 m -135.81 157.36 47.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -135.52 145.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.17 136.22 53.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.751 1.22 . . . . 10.0 108.092 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.06 137.66 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.839 -0.8 . . . . 10.0 108.839 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.7 mt -103.64 128.72 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 125.688 1.595 . . . . 10.0 107.252 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -151.45 168.54 24.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.471 0.482 . . . . 10.0 110.931 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.03 118.41 60.45 Favored Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 123.829 0.852 . . . . 10.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -67.56 7.94 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.31 3.34 . . . . 10.0 114.156 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.58 -48.99 9.66 Favored 'General case' 0 CA--C 1.526 0.019 0 CA-C-N 119.223 0.919 . . . . 10.0 108.549 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.83 -46.19 5.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.316 1.447 . . . . 10.0 110.84 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.2 m -113.65 130.12 56.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.859 2.464 . . . . 10.0 115.475 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.45 -177.93 30.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.114 -1.041 . . . . 10.0 111.179 158.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -39.59 -41.55 1.05 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 127.308 2.243 . . . . 10.0 111.036 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.22 -58.48 3.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.384 1.073 . . . . 10.0 113.082 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.24 -37.95 69.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.405 1.098 . . . . 10.0 108.653 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.252 1.6 mt -57.81 -57.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.099 -1.41 . . . . 10.0 111.053 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.28 -53.69 12.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.653 1.57 . . . . 10.0 110.225 175.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -42.79 -54.49 4.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.735 0.814 . . . . 10.0 112.765 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -44.79 67.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.331 -0.842 . . . . 10.0 111.52 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 10.2 mm -50.0 -46.87 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 119.484 1.038 . . . . 10.0 109.694 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -52.9 -47.06 68.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.176 0.59 . . . . 10.0 110.088 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.55 73.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.629 -0.669 . . . . 10.0 112.766 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -20.04 19.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.917 0.487 . . . . 10.0 110.854 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.31 29.34 7.56 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.165 0.888 . . . . 10.0 110.98 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -141.69 172.61 12.45 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 13' ' ' SER . 1.7 p80 -127.82 131.18 49.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 170.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.07 150.78 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.795 -1.093 . . . . 10.0 109.058 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.36 113.17 42.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.274 0.63 . . . . 10.0 109.528 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.7 mm -82.9 68.79 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -107.09 159.01 16.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.089 -1.449 . . . . 10.0 107.089 162.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.51 -80.99 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.818 -1.713 . . . . 10.0 108.818 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 tpp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.72 163.52 31.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.913 1.285 . . . . 10.0 107.617 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.45 104.82 4.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 166.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -116.14 125.07 51.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -83.33 160.79 21.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.931 -171.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -142.04 152.16 43.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.717 0.77 . . . . 10.0 109.823 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.98 133.62 34.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.38 2.272 . . . . 10.0 106.913 168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -113.09 148.39 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.965 -1.865 . . . . 10.0 105.965 159.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.11 124.95 25.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -156.21 167.72 29.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 -168.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.435 HE22 ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -100.59 151.09 22.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -171.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.76 156.52 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.459 ' HB3' ' CD2' ' A' ' 70' ' ' HIS . 5.7 t -115.32 140.92 48.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.71 59.29 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.243 -0.754 . . . . 10.0 114.115 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.9 125.92 14.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.859 1.329 . . . . 10.0 110.938 172.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -112.99 49.99 0.91 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t 51.35 -136.28 1.33 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.246 -1.359 . . . . 10.0 110.282 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 32.93 57.27 0.45 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.936 1.694 . . . . 10.0 114.021 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.05 20.79 7.2 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.05 1.34 . . . . 10.0 114.29 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -70.41 -60.66 2.14 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.203 -0.936 . . . . 10.0 108.66 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -58.84 -34.31 71.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.164 0.507 . . . . 10.0 111.428 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.72 79.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.97 -0.456 . . . . 10.0 110.475 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -55.6 -50.15 70.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.542 0.61 . . . . 10.0 110.707 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.445 HD11 ' CD2' ' A' ' 69' ' ' TYR . 83.8 mt -47.72 -60.97 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.46 -34.46 70.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.313 -0.555 . . . . 10.0 111.097 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -57.79 -35.12 70.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.016 -1.052 . . . . 10.0 110.751 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.96 -51.09 41.99 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.452 -1.059 . . . . 10.0 110.452 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 64' ' ' ILE . 97.4 mt -64.84 -30.55 71.56 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.288 -1.125 . . . . 10.0 113.17 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HA ' HG11 ' A' ' 34' ' ' VAL . 22.2 ttmt -58.07 -17.9 21.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.368 0.985 . . . . 10.0 111.658 171.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -15.44 58.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.253 1.205 . . . . 10.0 114.253 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.495 ' O ' HG12 ' A' ' 34' ' ' VAL . 99.2 mmm -77.24 134.82 66.69 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 120.537 1.517 . . . . 10.0 112.448 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 102.48 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.118 2.545 . . . . 10.0 111.006 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.89 -9.55 6.74 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.764 1.649 . . . . 10.0 110.272 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 31' ' ' MET . 4.5 p -65.48 155.94 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 118.218 1.009 . . . . 10.0 109.807 164.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -58.67 1.92 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 167.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.29 157.86 43.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.249 1.203 . . . . 10.0 114.249 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.93 37.88 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.391 1.876 . . . . 10.0 109.087 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -138.25 111.2 7.76 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.18 1.392 . . . . 10.0 108.572 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -84.54 140.35 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.629 0.771 . . . . 10.0 110.754 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -131.44 67.32 1.52 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.259 1.824 . . . . 10.0 111.526 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.37 -18.15 63.75 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.36 -16.42 22.59 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.017 0.371 . . . . 10.0 110.773 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -129.89 20.34 5.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.314 1.045 . . . . 10.0 110.093 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 47.12 37.92 5.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.348 0.976 . . . . 10.0 112.278 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.5 m -135.81 157.36 47.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -135.52 145.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.17 136.22 53.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.751 1.22 . . . . 10.0 108.092 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.06 137.66 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.839 -0.8 . . . . 10.0 108.839 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.7 mt -103.64 128.72 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 125.688 1.595 . . . . 10.0 107.252 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -151.45 168.54 24.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.471 0.482 . . . . 10.0 110.931 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.03 118.41 60.45 Favored Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 123.829 0.852 . . . . 10.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -67.56 7.94 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.31 3.34 . . . . 10.0 114.156 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.58 -48.99 9.66 Favored 'General case' 0 CA--C 1.526 0.019 0 CA-C-N 119.223 0.919 . . . . 10.0 108.549 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.83 -46.19 5.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.316 1.447 . . . . 10.0 110.84 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.2 m -113.65 130.12 56.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.859 2.464 . . . . 10.0 115.475 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.45 -177.93 30.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.114 -1.041 . . . . 10.0 111.179 158.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -39.59 -41.55 1.05 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 127.308 2.243 . . . . 10.0 111.036 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.22 -58.48 3.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.384 1.073 . . . . 10.0 113.082 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.24 -37.95 69.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.405 1.098 . . . . 10.0 108.653 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.509 HG12 HD22 ' A' ' 28' ' ' LEU 0.252 1.6 mt -57.81 -57.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.099 -1.41 . . . . 10.0 111.053 -176.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -53.69 12.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.653 1.57 . . . . 10.0 110.225 175.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -42.79 -54.49 4.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.735 0.814 . . . . 10.0 112.765 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -44.79 67.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.331 -0.842 . . . . 10.0 111.52 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.563 HD11 HD11 ' A' ' 28' ' ' LEU . 10.2 mm -50.0 -46.87 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 119.484 1.038 . . . . 10.0 109.694 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -52.9 -47.06 68.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.176 0.59 . . . . 10.0 110.088 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.55 73.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.629 -0.669 . . . . 10.0 112.766 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -20.04 19.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.917 0.487 . . . . 10.0 110.854 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.31 29.34 7.56 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.165 0.888 . . . . 10.0 110.98 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CD2' HD11 ' A' ' 24' ' ' ILE . 59.6 m-85 -141.69 172.61 12.45 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 13' ' ' SER . 1.7 p80 -127.82 131.18 49.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 170.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.07 150.78 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.795 -1.093 . . . . 10.0 109.058 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.36 113.17 42.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.274 0.63 . . . . 10.0 109.528 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.7 mm -82.9 68.79 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' HE22 ' A' ' 11' ' ' GLN . 1.5 tt0 -107.09 159.01 16.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.089 -1.449 . . . . 10.0 107.089 162.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.51 -80.99 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.818 -1.713 . . . . 10.0 108.818 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 tpp . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 112.351 0.5 . . . . 10.0 112.351 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -137.72 163.52 31.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.913 1.285 . . . . 10.0 107.617 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.45 104.82 4.11 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 166.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -116.14 125.07 51.84 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -83.33 160.79 21.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.931 -171.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -142.04 152.16 43.1 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.717 0.77 . . . . 10.0 109.823 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -83.98 133.62 34.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.38 2.272 . . . . 10.0 106.913 168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.1 tp -113.09 148.39 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 105.965 -1.865 . . . . 10.0 105.965 159.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.11 124.95 25.47 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 9.8 ptt? -156.21 167.72 29.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 -168.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.411 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -100.59 151.09 22.02 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -171.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -118.76 156.52 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.459 ' HB3' ' CD2' ' A' ' 70' ' ' HIS . 5.7 t -115.32 140.92 48.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 175.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.71 59.29 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.243 -0.754 . . . . 10.0 114.115 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.9 125.92 14.75 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.859 1.329 . . . . 10.0 110.938 172.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 p -112.99 49.99 0.91 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 t 51.35 -136.28 1.33 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.246 -1.359 . . . . 10.0 110.282 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 32.93 57.27 0.45 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.936 1.694 . . . . 10.0 114.021 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 58.05 20.79 7.2 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.05 1.34 . . . . 10.0 114.29 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -70.41 -60.66 2.14 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 121.203 -0.936 . . . . 10.0 108.66 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -58.84 -34.31 71.41 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.164 0.507 . . . . 10.0 111.428 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.72 79.22 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 121.97 -0.456 . . . . 10.0 110.475 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -55.6 -50.15 70.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.542 0.61 . . . . 10.0 110.707 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.445 HD11 ' CD2' ' A' ' 69' ' ' TYR . 83.8 mt -47.72 -60.97 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -71.46 -34.46 70.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.313 -0.555 . . . . 10.0 111.097 -170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -57.79 -35.12 70.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 121.016 -1.052 . . . . 10.0 110.751 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.96 -51.09 41.99 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.452 -1.059 . . . . 10.0 110.452 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD11 HD11 ' A' ' 64' ' ' ILE . 97.4 mt -64.84 -30.55 71.56 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.288 -1.125 . . . . 10.0 113.17 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HA ' HG11 ' A' ' 34' ' ' VAL . 22.2 ttmt -58.07 -17.9 21.02 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.368 0.985 . . . . 10.0 111.658 171.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -15.44 58.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.253 1.205 . . . . 10.0 114.253 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.495 ' O ' HG12 ' A' ' 34' ' ' VAL . 99.2 mmm -77.24 134.82 66.69 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 120.537 1.517 . . . . 10.0 112.448 -170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 102.48 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.118 2.545 . . . . 10.0 111.006 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.89 -9.55 6.74 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.764 1.649 . . . . 10.0 110.272 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 31' ' ' MET . 4.5 p -65.48 155.94 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 118.218 1.009 . . . . 10.0 109.807 164.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -58.67 1.92 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 167.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.29 157.86 43.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.249 1.203 . . . . 10.0 114.249 -177.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.47 129.93 37.88 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.391 1.876 . . . . 10.0 109.087 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -138.25 111.2 7.76 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.18 1.392 . . . . 10.0 108.572 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -84.54 140.35 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.629 0.771 . . . . 10.0 110.754 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -131.44 67.32 1.52 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.259 1.824 . . . . 10.0 111.526 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.37 -18.15 63.75 Favored 'General case' 0 C--N 1.334 -0.096 0 N-CA-C 112.743 0.645 . . . . 10.0 112.743 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.36 -16.42 22.59 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.017 0.371 . . . . 10.0 110.773 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -129.89 20.34 5.48 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.314 1.045 . . . . 10.0 110.093 174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 47.12 37.92 5.97 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.348 0.976 . . . . 10.0 112.278 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.5 m -135.81 157.36 47.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 -167.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -135.52 145.63 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.17 136.22 53.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.751 1.22 . . . . 10.0 108.092 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.06 137.66 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.839 -0.8 . . . . 10.0 108.839 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.7 mt -103.64 128.72 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 125.688 1.595 . . . . 10.0 107.252 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -151.45 168.54 24.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 123.471 0.482 . . . . 10.0 110.931 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -101.03 118.41 60.45 Favored Pre-proline 0 N--CA 1.444 -0.768 0 C-N-CA 123.829 0.852 . . . . 10.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -67.56 7.94 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.31 3.34 . . . . 10.0 114.156 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.58 -48.99 9.66 Favored 'General case' 0 CA--C 1.526 0.019 0 CA-C-N 119.223 0.919 . . . . 10.0 108.549 174.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.83 -46.19 5.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.316 1.447 . . . . 10.0 110.84 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.2 m -113.65 130.12 56.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.859 2.464 . . . . 10.0 115.475 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.45 -177.93 30.09 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.114 -1.041 . . . . 10.0 111.179 158.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.3 t -39.59 -41.55 1.05 Allowed 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 127.308 2.243 . . . . 10.0 111.036 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -45.22 -58.48 3.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.384 1.073 . . . . 10.0 113.082 173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.24 -37.95 69.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 122.405 1.098 . . . . 10.0 108.653 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.509 HG12 HD22 ' A' ' 28' ' ' LEU 0.252 1.6 mt -57.81 -57.73 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-N 114.099 -1.41 . . . . 10.0 111.053 -176.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.28 -53.69 12.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 120.653 1.57 . . . . 10.0 110.225 175.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -42.79 -54.49 4.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.735 0.814 . . . . 10.0 112.765 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -44.79 67.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 118.331 -0.842 . . . . 10.0 111.52 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.563 HD11 HD11 ' A' ' 28' ' ' LEU . 10.2 mm -50.0 -46.87 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 119.484 1.038 . . . . 10.0 109.694 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -52.9 -47.06 68.21 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.176 0.59 . . . . 10.0 110.088 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.55 73.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.629 -0.669 . . . . 10.0 112.766 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.6 -20.04 19.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.917 0.487 . . . . 10.0 110.854 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.31 29.34 7.56 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.165 0.888 . . . . 10.0 110.98 171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CD2' HD11 ' A' ' 24' ' ' ILE . 59.6 m-85 -141.69 172.61 12.45 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 13' ' ' SER . 1.7 p80 -127.82 131.18 49.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 170.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 p -88.07 150.78 3.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.795 -1.093 . . . . 10.0 109.058 174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.36 113.17 42.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.274 0.63 . . . . 10.0 109.528 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.7 mm -82.9 68.79 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -107.09 159.01 16.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.089 -1.449 . . . . 10.0 107.089 162.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.51 -80.99 0.3 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.818 -1.713 . . . . 10.0 108.818 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 -179.947 . . . . . . . . 1 1 . 1 stop_ save_